Last reviewed · How we verify

NCT06797466

Three Dimensional Virtual Reconstruction (3D) in Percutaneous Nephrolithotomy

Recruiting now NA Last updated 9 May 2025
What this trial tests

NA trial testing 3D imaging technique on the PCNL in PNL in 100 participants. Currently enrolling.

Timeline
21 January 2025
Primary endpoint
21 January 2025
31 October 2025

Quick facts

Lead sponsorAdiyaman University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment100
Start date21 January 2025
Primary completion21 January 2025
Estimated completion31 October 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Adiyaman University

Who can join

18 and older, any sex, with PNL or Stone, Kidney. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to investigate the effect of 3D imaging technique on the PCNL learning curve in specialist training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Adiyaman University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06797466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing